Equimune IV - Single Dose

An immunotherapeutic agent for the treatment of Equine Respiratory Disease Complex, (ERDC). The common causes of ERDC are equine herpesvirus (rhinopneumonitis), influenza A equine 1 and influenza A equine 2.

Dosage: For intravenous use only. The recommended dose for immunostimulation is 1.5 mL by intravenous injection into the jugular vein. Treatment may be repeated in 1 to 3 weeks. U.S. Vet. Lic. No. 289.